Huber Capital Management Has Cut By $16.85 Million Its Kbr (KBR) Stake; Tekla Capital Management Has Lowered By $10.02 Million Its Celgene (CELG) Position

February 23, 2018 - By Adrian Erickson

Huber Capital Management Llc decreased Kbr Inc (KBR) stake by 11.9% reported in 2017Q3 SEC filing. Huber Capital Management Llc sold 991,242 shares as Kbr Inc (KBR)’s stock declined 10.61%. The Huber Capital Management Llc holds 7.34 million shares with $131.22 million value, down from 8.33 million last quarter. Kbr Inc now has $2.19B valuation. The stock decreased 11.92% or $2.12 during the last trading session, reaching $15.66. About 3.27 million shares traded or 105.08% up from the average. KBR, Inc. (NYSE:KBR) has risen 5.89% since February 23, 2017 and is uptrending. It has underperformed by 10.81% the S&P500.

Tekla Capital Management Llc decreased Celgene Corporation (CELG) stake by 4.74% reported in 2017Q3 SEC filing. Tekla Capital Management Llc sold 69,080 shares as Celgene Corporation (CELG)’s stock declined 3.49%. The Tekla Capital Management Llc holds 1.39 million shares with $202.33M value, down from 1.46 million last quarter. Celgene Corporation now has $70.98B valuation. The stock increased 0.63% or $0.59 during the last trading session, reaching $94.37. About 1.15M shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since February 23, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Since September 5, 2017, it had 1 buying transaction, and 4 selling transactions for $4.31 million activity. Alles Mark J bought $299,594 worth of Celgene Corporation (NASDAQ:CELG) on Thursday, February 8. CASEY MICHAEL D also sold $1.29 million worth of Celgene Corporation (NASDAQ:CELG) on Tuesday, September 5. 18,500 Celgene Corporation (NASDAQ:CELG) shares with value of $1.77M were sold by KAPLAN GILLA. The insider Curran Terrie sold $248,498.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. They expect $1.78 EPS, up 16.34% or $0.25 from last year’s $1.53 per share. CELG’s profit will be $1.34B for 13.25 P/E if the $1.78 EPS becomes a reality. After $1.87 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -4.81% negative EPS growth.

Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 12 Hold. Therefore 58% are positive. Celgene Corporation had 132 analyst reports since July 21, 2015 according to SRatingsIntel. Cowen & Co maintained Celgene Corporation (NASDAQ:CELG) rating on Thursday, October 26. Cowen & Co has “Buy” rating and $150.0 target. The rating was maintained by BMO Capital Markets with “Outperform” on Tuesday, October 17. The firm earned “Outperform” rating on Friday, October 27 by BMO Capital Markets. The stock of Celgene Corporation (NASDAQ:CELG) has “Neutral” rating given on Friday, October 27 by Citigroup. On Monday, October 23 the stock rating was maintained by Morgan Stanley with “Underweight”. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, August 4 by Cowen & Co. Bernstein downgraded Celgene Corporation (NASDAQ:CELG) on Wednesday, December 27 to “Market Perform” rating. Wells Fargo maintained the stock with “Outperform” rating in Friday, December 4 report. On Wednesday, December 13 the stock rating was maintained by Leerink Swann with “Buy”. The firm earned “Buy” rating on Friday, October 27 by SunTrust.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.17, from 1.34 in 2017Q2. It dropped, as 44 investors sold CELG shares while 457 reduced holdings. 133 funds opened positions while 451 raised stakes. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Eulav Asset Mngmt reported 178,000 shares or 1.23% of all its holdings. Oregon Public Employees Retirement Fund accumulated 82,401 shares or 0.19% of the stock. Utd Svcs Automobile Association stated it has 0.4% in Celgene Corporation (NASDAQ:CELG). Hodges Management stated it has 1,507 shares or 0.01% of all its holdings. Miracle Mile Advisors Ltd Liability Corp has invested 0.04% of its portfolio in Celgene Corporation (NASDAQ:CELG). Stevens First Principles reported 55 shares. Tortoise Investment Mgmt Ltd Liability Corporation reported 0.04% stake. Klingenstein Fields And Co Ltd Limited Liability Company, New York-based fund reported 174,098 shares. Weiss Multi has 24,000 shares. Buffington Mohr Mcneal accumulated 19,715 shares. Bath Savings invested 3.52% in Celgene Corporation (NASDAQ:CELG). Massachusetts-based Peddock Cap Advsr Limited Liability has invested 1.07% in Celgene Corporation (NASDAQ:CELG). Btr Capital Mngmt owns 2,065 shares. Art Advsrs Ltd owns 158,000 shares. Amer Money Management Ltd Com holds 1.52% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 15,691 shares.

Tekla Capital Management Llc increased Thermo Fisher Scientific Inc. (NYSE:TMO) stake by 79,952 shares to 219,072 valued at $41.45 million in 2017Q3. It also upped Allergan Plc stake by 28,369 shares and now owns 338,979 shares. Epizyme Inc. (NASDAQ:EPZM) was raised too.

Among 10 analysts covering KBR Inc (NYSE:KBR), 6 have Buy rating, 1 Sell and 3 Hold. Therefore 60% are positive. KBR Inc had 26 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Citigroup with “Neutral” on Friday, October 27. The stock has “Buy” rating by Deutsche Bank on Tuesday, October 4. On Monday, May 2 the stock rating was downgraded by Johnson Rice to “Hold”. Credit Suisse maintained the stock with “Outperform” rating in Thursday, November 2 report. The firm has “Accumulate” rating given on Wednesday, October 5 by Johnson Rice. KeyBanc Capital Markets maintained the shares of KBR in report on Friday, August 25 with “Buy” rating. Goldman Sachs upgraded KBR, Inc. (NYSE:KBR) on Monday, March 28 to “Neutral” rating. Deutsche Bank maintained it with “Buy” rating and $20 target in Tuesday, October 24 report. The stock has “Sell” rating by Citigroup on Friday, November 13. M Partners upgraded KBR, Inc. (NYSE:KBR) on Monday, November 21 to “Buy” rating.

Investors sentiment decreased to 1.03 in 2017 Q3. Its down 0.12, from 1.15 in 2017Q2. It turned negative, as 18 investors sold KBR shares while 68 reduced holdings. 41 funds opened positions while 48 raised stakes. 141.73 million shares or 5.56% less from 150.07 million shares in 2017Q2 were reported. World Asset Mngmt has 10,978 shares. Cim Invest Mangement has invested 0.13% in KBR, Inc. (NYSE:KBR). Hsbc Public Ltd Liability Corporation holds 0% or 51,715 shares. Bnp Paribas Arbitrage Sa stated it has 63,925 shares or 0% of all its holdings. Renaissance Technology Llc has invested 0% in KBR, Inc. (NYSE:KBR). Qs Limited Liability invested 0% in KBR, Inc. (NYSE:KBR). Automobile Association has 435,640 shares for 0.02% of their portfolio. Massachusetts Ma stated it has 0.03% of its portfolio in KBR, Inc. (NYSE:KBR). Ing Groep Nv invested 0.01% in KBR, Inc. (NYSE:KBR). State Board Of Administration Of Florida Retirement accumulated 0.01% or 105,520 shares. Neuberger Berman Gru Ltd, New York-based fund reported 2.17M shares. 20.98 million are owned by Fmr Ltd. Proshare Limited Liability reported 19,473 shares stake. First Mercantile holds 0.02% of its portfolio in KBR, Inc. (NYSE:KBR) for 7,597 shares. Ig Investment Management Limited accumulated 573,372 shares or 0.05% of the stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts